Vos Ellen O'Connor

SEC source: 0001213900-26-105952 · ownership.xml · derivative · entry 1

Vos Ellen O'Connor · CIK 0001534357 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 250

Underlying: Common Stock · 250 shares

Expires 2036-09-30

F1 · security: The option was granted to the Reporting Person in accordance with the Issuer's Outside Director Compensation Plan, and the option was fully vested and exercisable on the grant date.

F1 · price: The option was granted to the Reporting Person in accordance with the Issuer's Outside Director Compensation Plan, and the option was fully vested and exercisable on the grant date.

F2 · balance_after: In accordance with Instruction 4 to this Form, column 9 reports only total beneficial ownership of the "class" of derivative security reported in Column 1. Options that have different exercise prices or vesting terms are not considered to be of the same "class."

SEC source: 0001213900-26-075026 · ownership.xml · derivative · entry 1

Vos Ellen O'Connor · CIK 0001534357 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 250

Underlying: Common Stock · 250 shares

Expires 2036-06-30

F1 · security: The option was granted to the Reporting Person in accordance with the Issuer's Outside Director Compensation Plan, and the option was fully vested and exercisable on the grant date.

F1 · price: The option was granted to the Reporting Person in accordance with the Issuer's Outside Director Compensation Plan, and the option was fully vested and exercisable on the grant date.

F2 · balance_after: In accordance with Instruction 4 to this Form, column 9 reports only total beneficial ownership of the "class" of derivative security reported in Column 1. Options that have different exercise prices or vesting terms are not considered to be of the same "class."

SEC source: 0001628280-26-042129 · wk-form4_1781113066.xml · nonDerivative · entry 1

Vos Ellen O'Connor · CIK 0001534357 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 107,159

F1 · shares: Grant of restricted stock units representing a contingent right to receive shares of OptimizeRx common stock. The restricted stock units will vest in full on the earlier of the first anniversary of the date of the grant or the date of the Company's next annual meeting of shareholders.

SEC source: 0001213900-26-041562 · ownership.xml · derivative · entry 1

Vos Ellen O'Connor · CIK 0001534357 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 250

Underlying: Common Stock · 250 shares

Expires 2036-03-31

F1 · security: The option was granted to the Reporting Person in accordance with the Issuer's Outside Director Compensation Plan, and the option was fully vested and exercisable on the grant date.

F1 · price: The option was granted to the Reporting Person in accordance with the Issuer's Outside Director Compensation Plan, and the option was fully vested and exercisable on the grant date.

F2 · balance_after: In accordance with Instruction 4 to this Form, column 9 reports only total beneficial ownership of the "class" of derivative security reported in Column 1. Options that have different exercise prices or vesting terms are not considered to be of the same "class."

SEC source: 0001213900-26-001370 · ownership.xml · derivative · entry 1

Vos Ellen O'Connor · CIK 0001534357 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 7,500

Underlying: Common Stock · 7,500 shares

Expires 2035-12-31

F1 · security: The option was granted to the Reporting Person in accordance with the Issuer's Outside Director Compensation Plan, and the option was fully vested and exercisable on the grant date.

F1 · price: The option was granted to the Reporting Person in accordance with the Issuer's Outside Director Compensation Plan, and the option was fully vested and exercisable on the grant date.

F2 · balance_after: In accordance with Instruction 4 to this Form, column 9 reports only total beneficial ownership of the "class" of derivative security reported in Column 1. Options that have different exercise prices or vesting terms are not considered to be of the same "class."

SEC source: 0001213900-25-095755 · ownership.xml · derivative · entry 1

Vos Ellen O'Connor · CIK 0001534357 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 7,500

Underlying: Common Stock · 7,500 shares

Expires 2035-09-30

F1 · security: The option was granted to the Reporting Person in accordance with the Issuer's Outside Director Compensation Plan, and the option was fully vested and exercisable on the grant date.

F1 · price: The option was granted to the Reporting Person in accordance with the Issuer's Outside Director Compensation Plan, and the option was fully vested and exercisable on the grant date.

F2 · balance_after: In accordance with Instruction 4 to this Form, column 9 reports only total beneficial ownership of the "class" of derivative security reported in Column 1. Options that have different exercise prices or vesting terms are not considered to be of the same "class."

SEC source: 0001213900-25-060673 · ownership.xml · derivative · entry 1

Vos Ellen O'Connor · CIK 0001534357 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 7,500

Underlying: Common Stock · 7,500 shares

Expires 2035-06-30

F1 · security: The option was granted to the Reporting Person in accordance with the Issuer's Outside Director Compensation Plan, and the option was fully vested and exercisable on the grant date.

F1 · price: The option was granted to the Reporting Person in accordance with the Issuer's Outside Director Compensation Plan, and the option was fully vested and exercisable on the grant date.

F2 · balance_after: In accordance with Instruction 4 to this Form, column 9 reports only total beneficial ownership of the "class" of derivative security reported in Column 1. Options that have different exercise prices or vesting terms are not considered to be of the same "class."

SEC source: 0001628280-25-031019 · wk-form4_1749760393.xml · nonDerivative · entry 1

Vos Ellen O'Connor · CIK 0001534357 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 72,642

F1 · shares: Grant of restricted stock units representing a contingent right to receive shares of OptimizeRx common stock. The restricted stock units will vest in full on the earlier of the first anniversary of the date of the grant or the date of the Company's next annual meeting of shareholders.

SEC source: 0001641172-25-014017 · ownership.xml · derivative · entry 2

Vos Ellen O'Connor · CIK 0001534357 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 5,312 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · derivative.exercise_price: Each restricted stock unit is the economic equivalent of one share of Aspira Women's Health Inc. Stock.

F3 · derivative.exercise_date: On August 22, 2024, the reporting person was granted 21,250 RSUs, 5,312 of which vested on June 4, 2025. The common stock into which such vested RSUs converted on June 4, 2025 is reported in Table I on this Form 4.

F3 · derivative.expiration_date: On August 22, 2024, the reporting person was granted 21,250 RSUs, 5,312 of which vested on June 4, 2025. The common stock into which such vested RSUs converted on June 4, 2025 is reported in Table I on this Form 4.

SEC source: 0001641172-25-014017 · ownership.xml · nonDerivative · entry 1

Vos Ellen O'Connor · CIK 0001534357 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 73,989

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: Represents the conversion upon vesting of restricted stock units (RSUs) into common stock. On August 22, 2024, the reporting person was granted 21,250 RSUs, 5,312 of which vested on June 4, 2025. Such RSUs were previously reported in Table II on a Form 4 filed with the SEC on August 26, 2024.

SEC source: 0001213900-25-027217 · ownership.xml · derivative · entry 1

Vos Ellen O'Connor · CIK 0001534357 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 7,500

Underlying: Common Stock · 7,500 shares

Expires 2035-03-31

F1 · security: The option was granted to the Reporting Person in accordance with the Issuer's Outside Director Compensation Plan, and the option was fully vested and exercisable on the grant date.

F1 · price: The option was granted to the Reporting Person in accordance with the Issuer's Outside Director Compensation Plan, and the option was fully vested and exercisable on the grant date.

F2 · balance_after: In accordance with Instruction 4 to this Form, column 9 reports only total beneficial ownership of the "class" of derivative security reported in Column 1. Options that have different exercise prices or vesting terms are not considered to be of the same "class."

SEC source: 0001641172-25-002278 · ownership.xml · derivative · entry 2

Vos Ellen O'Connor · CIK 0001534357 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 5,312

Underlying: Common Stock · 5,313 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · derivative.exercise_price: Each restricted stock unit is the economic equivalent of one share of Aspira Women's Health Inc. Stock.

F3 · derivative.exercise_date: On August 22, 2024, the reporting person was granted 21,250 RSUs, 5,313 of which vested on March 31, 2025. The common stock into which such vested RSUs converted on March 31, 2025 is reported in Table I on this Form 4.

F3 · derivative.expiration_date: On August 22, 2024, the reporting person was granted 21,250 RSUs, 5,313 of which vested on March 31, 2025. The common stock into which such vested RSUs converted on March 31, 2025 is reported in Table I on this Form 4.

SEC source: 0001641172-25-002278 · ownership.xml · nonDerivative · entry 1

Vos Ellen O'Connor · CIK 0001534357 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 68,677

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: Represents the conversion upon vesting of restricted stock units (RSUs) into common stock. On August 22, 2024, the reporting person was granted 21,250 RSUs, 5,313 of which vested on March 31, 2025. Such RSUs were previously reported in Table II on a Form 4 filed with the SEC on August 26, 2024.

SEC source: 0001213900-25-000732 · ownership.xml · derivative · entry 1

Vos Ellen O'Connor · CIK 0001534357 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 7,500

Underlying: Common Stock · 7,500 shares

Expires 2034-12-31

F1 · security: The option was granted to the Reporting Person in accordance with the Issuer's Outside Director Compensation Plan, and the option was fully vested and exercisable on the grant date.

F1 · price: The option was granted to the Reporting Person in accordance with the Issuer's Outside Director Compensation Plan, and the option was fully vested and exercisable on the grant date.

F2 · balance_after: In accordance with Instruction 4 to this Form, column 9 reports only total beneficial ownership of the "class" of derivative security reported in Column 1. Options that have different exercise prices or vesting terms are not considered to be of the same "class."

SEC source: 0001562180-25-000277 · primarydocument.xml · derivative · entry 2

Vos Ellen O'Connor · CIK 0001534357 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 10,625

Underlying: Common Stock · 5,312 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · derivative.exercise_price: Each restricted stock unit is the economic equivalent of one share of Aspira Women's Health Inc. Stock.

F3 · derivative.exercise_date: On August 22, 2024, the reporting person was granted 21,250 RSUs, 5,312 of which vested on December 31, 2024. The common stock into which such vested RSUs converted on December 31, 2024 is reported in Table I on this Form 4.

F3 · derivative.expiration_date: On August 22, 2024, the reporting person was granted 21,250 RSUs, 5,312 of which vested on December 31, 2024. The common stock into which such vested RSUs converted on December 31, 2024 is reported in Table I on this Form 4.

SEC source: 0001562180-25-000277 · primarydocument.xml · nonDerivative · entry 1

Vos Ellen O'Connor · CIK 0001534357 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 63,364

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: Represents the conversion upon vesting of restricted stock units (RSUs) into common stock. On August 22, 2024, the reporting person was granted 21,250 RSUs, 5,312 of which vested on December 31, 2024. Such RSUs were previously reported in Table II on a Form 4 filed with the SEC on August 26, 2024.

SEC source: 0001213900-24-084302 · ownership.xml · derivative · entry 1

Vos Ellen O'Connor · CIK 0001534357 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 7,500

Underlying: Common Stock · 7,500 shares

Expires 2034-09-30

F1 · security: The option was granted to the Reporting Person in accordance with the Issuer's Outside Director Compensation Plan, and the option was fully vested and exercisable on the grant date.

F1 · price: The option was granted to the Reporting Person in accordance with the Issuer's Outside Director Compensation Plan, and the option was fully vested and exercisable on the grant date.

F2 · balance_after: In accordance with Instruction 4 to this Form, column 9 reports only total beneficial ownership of the "class" of derivative security reported in Column 1. Options that have different exercise prices or vesting terms are not considered to be of the same "class."

SEC source: 0001562180-24-007233 · primarydocument.xml · derivative · entry 2

Vos Ellen O'Connor · CIK 0001534357 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 15,937

Underlying: Common Stock · 5,313 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · derivative.exercise_price: Each restricted stock unit is the economic equivalent of one share of Aspira Women's Health Inc. Stock.

F3 · derivative.exercise_date: On August 22, 2024, the reporting person was granted 21,250 RSUs, 5,313 of which vested on September 30, 2024. The common stock into which such vested RSUs converted on September 30, 2024 is reported in Table I on this Form 4.

F3 · derivative.expiration_date: On August 22, 2024, the reporting person was granted 21,250 RSUs, 5,313 of which vested on September 30, 2024. The common stock into which such vested RSUs converted on September 30, 2024 is reported in Table I on this Form 4.

SEC source: 0001562180-24-007233 · primarydocument.xml · nonDerivative · entry 1

Vos Ellen O'Connor · CIK 0001534357 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 58,052

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: Represents the conversion upon vesting of restricted stock units (RSUs) into common stock. On August 22, 2024, the reporting person was granted 21,250 RSUs, 5,313 of which vested on September 30, 2024. Such RSUs were previously reported in Table II on a Form 4 filed with the SEC on August 26, 2024.

SEC source: 0000950170-24-100573 · ownership.xml · derivative · entry 1

Vos Ellen O'Connor · CIK 0001534357 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 21,250

Underlying: Common Stock · 21,250 shares

Expires not disclosed

F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of the Issuer's Common Stock.

F2 · derivative.exercise_date: The award will vest in four substantially equal installments on September 30, 2024, December 31, 2024, March 31, 2025 and the date of the annual shareholders' meeting, subject to the Reporting Person's continued service to the Issuer through the applicable vesting dates.

F2 · derivative.expiration_date: The award will vest in four substantially equal installments on September 30, 2024, December 31, 2024, March 31, 2025 and the date of the annual shareholders' meeting, subject to the Reporting Person's continued service to the Issuer through the applicable vesting dates.

SEC source: 0000950170-24-096244 · ownership.xml · nonDerivative · entry 1

Vos Ellen O'Connor · CIK 0001534357 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 52,739

F1 · shares: The shares of common stock represent restricted stock units with the contingent right to receive one share of common stock of Aspira Women's Health Inc. for each restricted stock unit. The restricted stock unit vested in full on August 12, 2024.

SEC source: 0000950170-24-082709 · ownership.xml · derivative · entry 2

Vos Ellen O'Connor · CIK 0001534357 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 3,268

Underlying: Common Stock, par value $0.001 · 3,268 shares

Expires 2027-07-09

F1 · price: Each share of common stock was purchased together with one warrant to purchase one share of common stock at a price of $1.53.

SEC source: 0000950170-24-082709 · ownership.xml · nonDerivative · entry 1

Vos Ellen O'Connor · CIK 0001534357 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 36,146

F1 · price: Each share of common stock was purchased together with one warrant to purchase one share of common stock at a price of $1.53.

SEC source: 0001213900-24-058705 · ownership.xml · derivative · entry 1

Vos Ellen O'Connor · CIK 0001534357 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 7,500

Underlying: Common Stock · 7,500 shares

Expires 2034-06-30

F1 · security: The option was granted to the Reporting Person in accordance with the Issuer's Outside Director Compensation Plan, and the option was fully vested and exercisable on the grant date.

F1 · price: The option was granted to the Reporting Person in accordance with the Issuer's Outside Director Compensation Plan, and the option was fully vested and exercisable on the grant date.

F2 · balance_after: In accordance with Instruction 4 to this Form, column 9 reports only total beneficial ownership of the "class" of derivative security reported in Column 1. Options that have different exercise prices or vesting terms are not considered to be of the same "class."

SEC source: 0001628280-24-027715 · wk-form4_1718142583.xml · nonDerivative · entry 2

Vos Ellen O'Connor · CIK 0001534357 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 62,774

F2 · shares: Grant of restricted stock units representing a contingent right to receive shares of OptimizeRx common stock. The restricted stock units will vest in full on the earlier of the first anniversary of the date of grant or the date of the Company's next annual meeting of shareholders.

SEC source: 0001628280-24-027715 · wk-form4_1718142583.xml · derivative · entry 3

Vos Ellen O'Connor · CIK 0001534357 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 10,061 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_price: Restricted stock units convert into common stock on a one-for-one basis.

F3 · derivative.exercise_date: On June 7, 2023 the reporting person was granted 10,061 restricted stock units which vested in full on June 5, 2024.

F3 · derivative.expiration_date: On June 7, 2023 the reporting person was granted 10,061 restricted stock units which vested in full on June 5, 2024.

SEC source: 0001628280-24-027715 · wk-form4_1718142583.xml · nonDerivative · entry 1

Vos Ellen O'Connor · CIK 0001534357 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 49,488

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · price: Restricted stock units convert into common stock on a one-for-one basis.

SEC source: 0001213900-24-029547 · ownership.xml · derivative · entry 1

Vos Ellen O'Connor · CIK 0001534357 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 7,500

Underlying: Common Stock · 7,500 shares

Expires 2034-03-31

F1 · security: The option was granted to the Reporting Person in accordance with the Issuer's Outside Director Compensation Plan, and the option was fully vested and exercisable on the grant date.

F1 · price: The option was granted to the Reporting Person in accordance with the Issuer's Outside Director Compensation Plan, and the option was fully vested and exercisable on the grant date.

F2 · balance_after: In accordance with Instruction 4 to this Form, column 9 reports only total beneficial ownership of the "class" of derivative security reported in Column 1. Options that have different exercise prices or vesting terms are not considered to be of the same "class."

SEC source: 0001213900-24-000366 · ownership.xml · derivative · entry 1

Vos Ellen O'Connor · CIK 0001534357 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 7,500

Underlying: Common Stock · 7,500 shares

Expires 2033-12-29

F1 · security: The option was granted to the Reporting Person in accordance with the Issuer's Outside Director Compensation Plan, and the option was fully vested and exercisable on the grant date.

F1 · price: The option was granted to the Reporting Person in accordance with the Issuer's Outside Director Compensation Plan, and the option was fully vested and exercisable on the grant date.

F2 · balance_after: In accordance with Instruction 4 to this Form, column 9 reports only total beneficial ownership of the "class" of derivative security reported in Column 1. Options that have different exercise prices or vesting terms are not considered to be of the same "class."

SEC source: 0001013762-23-000714 · ownership.xml · derivative · entry 1

Vos Ellen O'Connor · CIK 0001534357 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 7,500

Underlying: Common Stock · 7,500 shares

Expires 2033-09-30

F1 · security: The option was granted to the Reporting Person in accordance with the Issuer's Outside Director Compensation Plan, and the option was fully vested and exercisable on the grant date.

F1 · price: The option was granted to the Reporting Person in accordance with the Issuer's Outside Director Compensation Plan, and the option was fully vested and exercisable on the grant date.

F2 · balance_after: In accordance with Instruction 4 to this Form, column 9 reports only total beneficial ownership of the "class" of derivative security reported in Column 1. Options that have different exercise prices or vesting terms are not considered to be of the same "class."

SEC source: 0000926617-23-000061 · certent-form4.xml · nonDerivative · entry 1

Vos Ellen O'Connor · CIK 0001534357 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 32,878

SEC source: 0001213900-23-054870 · ownership.xml · derivative · entry 1

Vos Ellen O'Connor · CIK 0001534357 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 7,500

Underlying: Common Stock · 7,500 shares

Expires 2033-06-30

F1 · security: The option was granted to the Reporting Person in accordance with the Issuer's Outside Director Compensation Plan, and the option was fully vested and exercisable on the grant date.

F1 · price: The option was granted to the Reporting Person in accordance with the Issuer's Outside Director Compensation Plan, and the option was fully vested and exercisable on the grant date.

F2 · balance_after: In accordance with Instruction 4 to this Form, column 9 reports only total beneficial ownership of the "class" of derivative security reported in Column 1. Options that have different exercise prices or vesting terms are not considered to be of the same "class."

SEC source: 0001628280-23-029926 · wk-form4_1692365366.xml · derivative · entry 3

Vos Ellen O'Connor · CIK 0001534357 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 10,061

Underlying: Common Stock · 10,061 shares

Expires not disclosed

F3 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of OptimizeRx common stock.

F4 · derivative.exercise_date: The restricted stock units will vest in full on the earlier of the first anniversary of the date of grant or the date of the Company's next annual meeting of shareholders.

F4 · derivative.expiration_date: The restricted stock units will vest in full on the earlier of the first anniversary of the date of grant or the date of the Company's next annual meeting of shareholders.

SEC source: 0001628280-23-029926 · wk-form4_1692365366.xml · derivative · entry 2

Vos Ellen O'Connor · CIK 0001534357 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 4,637 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_price: Restricted stock units convert into common stock on a one-for-one basis.

F2 · derivative.exercise_date: On June 7, 2022 the reporting person was granted 4,637 restricted stock units which vested in full on June 7, 2023.

F2 · derivative.expiration_date: On June 7, 2022 the reporting person was granted 4,637 restricted stock units which vested in full on June 7, 2023.

SEC source: 0001628280-23-029926 · wk-form4_1692365366.xml · nonDerivative · entry 1

Vos Ellen O'Connor · CIK 0001534357 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 39,427

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · price: Restricted stock units convert into common stock on a one-for-one basis.

SEC source: 0001562180-23-004817 · primarydocument.xml · nonDerivative · entry 1

Vos Ellen O'Connor · CIK 0001534357 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 29,109

F1 · shares: 6,509 of the restricted stock units will vest on June 1, 2023, 11,300 of the restricted stock units will vest on September 1, 2023 and 11,300 of the restricted stock units will vest on December 1, 2023.

SEC source: 0001213900-23-026199 · ownership.xml · derivative · entry 1

Vos Ellen O'Connor · CIK 0001534357 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 7,500

Underlying: Common Stock · 7,500 shares

Expires 2033-03-31

F1 · security: The option was granted to the Reporting Person in accordance with the Issuer's Outside Director Compensation Plan, and the option was fully vested and exercisable on the grant date.

F2 · balance_after: In accordance with Instruction 4 to this Form, column 9 reports only total beneficial ownership of the "class" of derivative security reported in Column 1. Options that have different exercise prices or vesting terms are not considered to be of the same "class."

SEC source: 0001628280-23-010319 · wf-form4_168053867340398.xml · derivative · entry 2

Vos Ellen O'Connor · CIK 0001534357 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 657

Underlying: Common Stock · 657 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_price: Restricted stock units convert into common stock on a one-for-one basis.

F2 · derivative.exercise_date: On March 30, 2022 the reporting person was granted 657 restricted stock units which vested in full on March 30, 2023.

F2 · derivative.expiration_date: On March 30, 2022 the reporting person was granted 657 restricted stock units which vested in full on March 30, 2023.

SEC source: 0001628280-23-010319 · wf-form4_168053867340398.xml · nonDerivative · entry 1

Vos Ellen O'Connor · CIK 0001534357 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 34,790

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · price: Restricted stock units convert into common stock on a one-for-one basis.

SEC source: 0001019056-23-000012 · vos.xml · derivative · entry 1

Vos Ellen O'Connor · CIK 0001534357 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 7,500

Underlying: Common Stock · 7,500 shares

Expires 2032-12-31

F1 · security: The option was granted to the Reporting Person in accordance with the Issuer's Outside Director Compensation Plan, and the option was fully vested and exercisable on the grant date.

F2 · balance_after: In accordance with Instruction 4 to this Form, column 9 reports only total beneficial ownership of the "class" of derivative security reported in Column 1. Options that have different exercise prices or vesting terms are not considered to be of the same "class."

SEC source: 0001628280-23-000213 · wf-form4_167286634698904.xml · derivative · entry 2

Vos Ellen O'Connor · CIK 0001534357 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 409 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_price: Restricted stock units convert into common stock on a one-for-one basis.

F2 · derivative.exercise_date: On December 30, 2021 the reporting person was granted 409 restricted stock units which vested in full on December 30, 2022.

F2 · derivative.expiration_date: On December 30, 2021 the reporting person was granted 409 restricted stock units which vested in full on December 30, 2022.

SEC source: 0001628280-23-000213 · wf-form4_167286634698904.xml · nonDerivative · entry 1

Vos Ellen O'Connor · CIK 0001534357 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 34,133

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · price: Restricted stock units convert into common stock on a one-for-one basis.

SEC source: 0001019056-22-000617 · vos.xml · derivative · entry 1

Vos Ellen O'Connor · CIK 0001534357 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 7,500

Underlying: Common Stock · 7,500 shares

Expires 2032-09-30

F1 · security: The option was granted to the Reporting Person in accordance with the Issuer's Outside Director Compensation Plan, and the option was fully vested and exercisable on the grant date.

F2 · balance_after: In accordance with Instruction 4 to this Form, column 9 reports only total beneficial ownership of the "class" of derivative security reported in Column 1. Options that have different exercise prices or vesting terms are not considered to be of the same "class."

SEC source: 0001628280-22-025807 · wf-form4_166457022239063.xml · derivative · entry 2

Vos Ellen O'Connor · CIK 0001534357 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 334 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_price: Restricted stock units convert into common stock on a one-for-one basis.

F2 · derivative.exercise_date: On September 29, 2021 the reporting person was granted 334 restricted stock units which vested in full on September 29, 2022.

F2 · derivative.expiration_date: On September 29, 2021 the reporting person was granted 334 restricted stock units which vested in full on September 29, 2022.

SEC source: 0001628280-22-025807 · wf-form4_166457022239063.xml · nonDerivative · entry 1

Vos Ellen O'Connor · CIK 0001534357 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 33,724

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · price: Restricted stock units convert into common stock on a one-for-one basis.

SEC source: 0001213900-22-049031 · ownership.xml · nonDerivative · entry 1

Vos Ellen O'Connor · CIK 0001534357 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 500

SEC source: 0001019056-22-000548 · vos.xml · derivative · entry 1

Vos Ellen O'Connor · CIK 0001534357 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,648

Underlying: Common Stock · 1,648 shares

Expires 2032-07-19

F1 · security: The option was granted to the Reporting Person in accordance with the Issuer's Outside Director Compensation Plan, and the option was fully vested and exercisable on the grant date.

F2 · balance_after: In accordance with Instruction 4 to this Form, column 9 reports only total beneficial ownership of the "class" of derivative security reported in Column 1. Options that have different exercise prices or vesting terms are not considered to be of the same "class."

SEC source: 0001213900-22-032532 · ownership.xml · derivative · entry 1

Vos Ellen O'Connor · CIK 0001534357 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 4,637

Underlying: Common Stock · 4,637 shares

Expires not disclosed

F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of OptimizeRx common stock.

F2 · derivative.exercise_date: The restricted stock units will vest in full on the earlier of the first anniversary of the date of grant or the date of the Company's next annual meeting of shareholders.

F2 · derivative.expiration_date: The restricted stock units will vest in full on the earlier of the first anniversary of the date of grant or the date of the Company's next annual meeting of shareholders.

SEC source: 0001213900-22-017499 · ownership.xml · derivative · entry 1

Vos Ellen O'Connor · CIK 0001534357 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 657

Underlying: Common Stock · 657 shares

Expires not disclosed

F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of OptimizeRx common stock.

F2 · derivative.exercise_date: The restricted stock units vest on March 30, 2023.

F2 · derivative.expiration_date: The restricted stock units vest on March 30, 2023.

SEC source: 0001213900-22-000277 · ownership.xml · derivative · entry 1

Vos Ellen O'Connor · CIK 0001534357 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 743

Underlying: Common Stock · 409 shares

Expires not disclosed

F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of the issuer's common stock.

F2 · derivative.exercise_date: Grant to the Reporting Person of restricted stock units under the OptimizeRx Corp. 2021 Equity Incentive Plan. The restricted stock units granted vest on December 30, 2022, subject to continued service to the issuer through the vesting date. This restricted stock units granted are subject to accelerated vesting in the event that the recipient is subject to a qualified termination within a specified period of time prior to or following the closing of a change in control transaction.

F3 · derivative.expiration_date: Not applicable.